148960-37-6 Usage
Chiral compound
It has a non-superimposable mirror image, meaning it exists in different forms that are mirror images of each other, which can have different effects in biological systems.
Ammine
1H-Inden-1-amine,6-fluoro-2,3-dihydro, (+)-(9CI) is an amine, which is a derivative of ammonia (NH3) with one or more hydrogen atoms replaced by organic groups.
Fluorine-substituted derivative
This chemical contains a fluorine atom, which is a halogen that is substituted for a hydrogen atom in the 1H-indenamine structure.
Pharmaceutical research
It is commonly used as a building block for the synthesis of various biologically active compounds, making it valuable in the development of new drugs and therapies.
Medicinal chemistry and drug discovery
The unique structural properties and potential biological activities of 1H-Inden-1-amine,6-fluoro-2,3-dihydro, (+)-(9CI) make it a promising candidate for the development of new medications.
Safety precautions
As with all chemicals, proper handling and safety measures should be taken when working with 1H-Inden-1-amine,6-fluoro-2,3-dihydro, (+)-(9CI) to minimize the risk of exposure or accidents.
Check Digit Verification of cas no
The CAS Registry Mumber 148960-37-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,8,9,6 and 0 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 148960-37:
(8*1)+(7*4)+(6*8)+(5*9)+(4*6)+(3*0)+(2*3)+(1*7)=166
166 % 10 = 6
So 148960-37-6 is a valid CAS Registry Number.
148960-37-6Relevant articles and documents
INHIBITOR OF JAK1 AND JAK2
-
Page/Page column 7, (2014/01/08)
The present invention provides an amino pyrazole compound, which is 3-[(lR)-6-fluoro-2,3-dihydro-1H-inden-l-yl]-N-(3- methyl-IH- pyrazol-5-yl)-3H-imidazo[4,5-b]pyridin-5-amine, or a pharmaceutically acceptable salt thereof, that inhibits JAK1 and JAK2 and, therefore may be useful in treating cancer.
AMINO-TETRAZOLES ANALOGUES AND METHODS OF USE
-
Page/Page column 160, (2010/02/14)
A compound having Formula (I) or Formula (II) is disclosed as an P2X7 antagonist, wherein A, B, C, Y, Y, Z, m, v, R1, R2, R3, R4, and R 5, are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X7 are also disclosed.
